openPR Logo
Press release

Chagas Disease Market Surges Amid Tariff Challenges: Bayer, Novartis, and Elea Phoenix Lead the Way

04-24-2025 09:23 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Chagas Disease Market

Chagas Disease Market

The global Chagas disease market reached US$ 268 million in 2023 and is expected to reach US$ 467 million by 2031, growing with a CAGR of 7.2% during the forecast period 2024-2031.

Chagas Disease Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/chagas-disease-market?rk

The Chagas Disease Market involves treatments for a parasitic disease caused by Trypanosoma cruzi, prevalent in Latin America. Current treatments are limited and most effective in early stages. Vector control and diagnostics are also part of the market. Rising awareness and international health efforts are expanding access to care. Drug development is focusing on safer, more effective options.

List of the Key Players in the Chagas Disease Market:

Bayer AG, Novartis AG, Laboratorio Elea Phoenix, Maprimed, Nortec Quimica SA, Upsher-Smith Laboratories, Inc., Merck and Co., ChemFish Tokyo Co., Ltd., Anant Pharmaceuticals Pvt. Ltd., and InBios International Inc.

Industry Development:

In February 2024, Brazil's federal government, in partnership with the World Health Organization (WHO), launched the Healthy Brazil program. This initiative is a public policy aimed at combating 14 diseases that predominantly affect socially vulnerable populations, including malaria, Chagas disease, HIV, and tuberculosis. The program seeks to either eliminate these conditions as public health concerns or significantly reduce their incidence, showcasing a commitment to improving health equity in Brazil.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=chagas-disease-market?rk

Assessing the Effects of U.S. Tariffs on the Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Chagas Disease Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/chagas-disease-market?rk

Segment Covered in the Chagas Disease Market:

By Type: Acute Chagas Disease, Chronic Chagas Disease.

By Drugs: Benznidazole , Nifurtimox, Others.

By Route of administration: Oral , Parenteral.

By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.

Regional Analysis for Chagas Disease Market:

The regional analysis of the Chagas Disease Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/chagas-disease-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Chagas Disease market?

➠ Who are the leading manufacturers in the global Chagas Disease industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Chagas Disease industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Chagas Disease market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/chagas-disease-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chagas Disease Market Surges Amid Tariff Challenges: Bayer, Novartis, and Elea Phoenix Lead the Way here

News-ID: 3985431 • Views:

More Releases from DataM Intelligence 4market Research LLP

Automotive Turbocharger Market to Reach USD 16.5 Billion by 2030 at 10.3% CAGR, Dominated by Asia-Pacific with 40% Share, Led by BorgWarner Inc., Garrett Motion Inc., Continental AG, Mitsubishi Heavy Industries, Ltd., and IHI Corporation
Automotive Turbocharger Market to Reach USD 16.5 Billion by 2030 at 10.3% CAGR, …
The Automotive turbocharger market reached USD 13.5 billion in 2022 and is expected to reach USD 16.5 billion by 2030, growing with a CAGR of 10.3% from 2023 to 2030. as vehicle manufacturers increasingly adopt turbocharging technology to enhance engine efficiency, performance, and emissions compliance. Growth is supported by rising demand across key vehicle segments including passenger cars, commercial vehicles, and light-duty trucks, driven by stringent fuel economy and regulatory
Digital Audio Workstation Market to Reach US$ 7.3 Billion by 2029 at 16.1% CAGR, Dominated by North America with 35% Share, Led by Avid Technology, Inc., Ableton AG, Steinberg Media Technologies GmbH, Apple Inc., and Image-Line Software
Digital Audio Workstation Market to Reach US$ 7.3 Billion by 2029 at 16.1% CAGR, …
The Digital Audio Workstation (DAW) Market reached approximately US$ 3.3 billion in 2024 and is expected to grow to around US$ 7.3 billion by 2029, expanding at a CAGR of about 16.1% from 2025 to 2029 as demand for advanced music production, sound design, and audio editing solutions continues to rise across professional and consumer segments. Growth is supported by increasing adoption across key application areas such as music production, post-production,
Fracture Fixation Products Market to Reach US$ 16.34 Billion by 2031 at 7.8% CAGR, Dominated by North America with 35% Share, Led by Stryker Corporation, DePuy Synthes, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, and Medtronic plc
Fracture Fixation Products Market to Reach US$ 16.34 Billion by 2031 at 7.8% CAG …
The Global Fracture Fixation Products Market reached US$ 9.1 billion in 2023 and is expected to reach US$ 16.34 billion by 2031, growing at a CAGR of 7.8% from 2024 to 2031 as orthopedic care providers and surgical centers increasingly adopt advanced fixation solutions to improve patient outcomes and reduce recovery time. Growth is supported by rising demand across key product segments such as plates & screws, intramedullary nails, external
LNG Storage Tank Market to Reach USD 6.7 Billion by 2030 Driven by Rising LNG Infrastructure Investments, Energy Security Initiatives, and Advanced Cryogenic Technologies
LNG Storage Tank Market to Reach USD 6.7 Billion by 2030 Driven by Rising LNG In …
The LNG Storage Tank Market reached USD 4.5 billion in 2022 and is expected to reach USD 6.7 billion by 2030, growing at a CAGR of 5.5% during the forecast period 2024-2031. Growth is driven by increasing global demand for liquefied natural gas (LNG) as a cleaner alternative to conventional fossil fuels, particularly in power generation, industrial applications, and transportation. Rising investments in LNG infrastructure, including terminals, regasification facilities, and storage

All 5 Releases


More Releases for Chagas

Chagas Disease Market Emerging Trends and Growth Prospects 2034
Introduction Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening parasitic illness caused by Trypanosoma cruzi. It is transmitted primarily through triatomine bugs (kissing bugs), blood transfusions, congenital infections, or contaminated food. Once considered confined to Latin America, globalization, migration, and increased travel have made Chagas disease a global public health concern. While millions are infected worldwide, the disease remains classified as a neglected tropical disease (NTD), with limited treatment
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 . Chagas Disease Treatment Market Overview Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,